GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Price-to-Tangible-Book

2cureX AB (OSTO:2CUREX) Price-to-Tangible-Book : 0.35 (As of May. 17, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Price-to-Tangible-Book?

As of today (2024-05-17), 2cureX AB's share price is kr0.351. 2cureX AB's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was kr1.01. Hence, 2cureX AB's Price to Tangible Book Ratio of today is 0.35.

The historical rank and industry rank for 2cureX AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:2CUREX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.29   Med: 4.12   Max: 13.87
Current: 0.35

During the past 8 years, 2cureX AB's highest Price to Tangible Book Ratio was 13.87. The lowest was 0.29. And the median was 4.12.

OSTO:2CUREX's Price-to-Tangible-Book is ranked better than
96.98% of 1226 companies
in the Biotechnology industry
Industry Median: 2.85 vs OSTO:2CUREX: 0.35

A closely related ratio is called PB Ratio. As of today, 2cureX AB's share price is kr0.351. 2cureX AB's Book Value per Sharefor the quarter that ended in Sep. 2023 was kr1.01. Hence, 2cureX AB's P/B Ratio of today is 0.35.


2cureX AB Price-to-Tangible-Book Historical Data

The historical data trend for 2cureX AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Price-to-Tangible-Book Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
Get a 7-Day Free Trial 10.80 6.04 4.18 3.95 3.33

2cureX AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.27 3.33 3.17 2.64 3.21

Competitive Comparison of 2cureX AB's Price-to-Tangible-Book

For the Biotechnology subindustry, 2cureX AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Price-to-Tangible-Book falls into.



2cureX AB Price-to-Tangible-Book Calculation

2cureX AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2023 )
=0.351/1.008
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


2cureX AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


2cureX AB (OSTO:2CUREX) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines